These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2624715)

  • 1. [New technic for purification of lymphocytes for HLA typing].
    Mantovani V; Calanca F; Barboni P
    Boll Soc Ital Biol Sper; 1989 Oct; 65(10):967-73. PubMed ID: 2624715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontogeny of the MHC antigens on human trophoblast cells during the first trimester of pregnancy.
    Montgomery B; Lala PK
    J Immunol; 1983 Nov; 131(5):2348-55. PubMed ID: 6415163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
    Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
    J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical importance of pre-morteum blood lymphocytes in cadaver donor tissue typing.
    Vaidya S; Orchard P; Schroeder N; Haneke R; Brooks K; Thomas A; Corba A; Asfour A; Fish JC
    Clin Transplant; 1995 Jun; 9(3 Pt 1):165-70. PubMed ID: 7549055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Typing of HLA-DR antigens on B lymphocytes--a problem of B-lymphocyte-suspension quality and specificity of anti-HLA-DR serums].
    Májský A
    Vnitr Lek; 1978 Dec; 24(12):1209-16. PubMed ID: 310195
    [No Abstract]   [Full Text] [Related]  

  • 7. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
    Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
    Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic effector function in HLA-associated autoimmune diseases.
    Puglisi F; Capuano P; Verzillo F; Simone M; Laurentaci C; Catalano G
    Panminerva Med; 1999 Dec; 41(4):319-22. PubMed ID: 10705713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T; Davidson WF
    J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell activity in HLA-associated autoimmune diseases.
    Puglisi F; Capuano P; Simone M; Verzillo F; Laurentaci C
    Panminerva Med; 1999 Dec; 41(4):315-7. PubMed ID: 10705712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of normal and transformed lymphocyte subsets of nonhuman primates with monoclonal antibodies to human lymphocytes.
    Neubauer RH; Briggs CJ; Noer KB; Rabin H
    J Immunol; 1983 Mar; 130(3):1323-9. PubMed ID: 6296233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microcytotoxic HLA typing of cells directly isolated from blood by means of antibody-coated microspheres.
    Vartdal F; Bratlie A; Gaudernack G; Funderud S; Lea T; Thorsby E
    Transplant Proc; 1987 Feb; 19(1 Pt 1):655-7. PubMed ID: 3152705
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-2 activated lymphocytes show improved sensitivity for class 1 HLA typing.
    Hirose M; Shinohara K; Watanabe H; Lee E; Kuroda Y
    Tokushima J Exp Med; 1996 Dec; 43(3-4):87-91. PubMed ID: 9100455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique.
    Vartdal F; Gaudernack G; Funderud S; Bratlie A; Lea T; Ugelstad J; Thorsby E
    Tissue Antigens; 1986 Nov; 28(5):301-12. PubMed ID: 3469787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
    Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
    Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.
    Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC
    J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing effect of anti-HLA class I monoclonal antibodies on T cell proliferation induced via CD2 molecule.
    Turco MC; de Felice M; Corbo L; Giarrusso PC; Yang SY; Ferrone S; Venuta S
    J Immunol; 1988 Oct; 141(7):2275-81. PubMed ID: 3262654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.